Our research demonstrates, for the first time, that butyrate and acetate, at concentrations raised under pharmacological interventions, improve endothelial dysfunction induced by the prohypertensive agent AngII by increasing the bioavailability of NO involving GPR activation. Here, ALDH18A1 is linked to endothelial dysfunction.